Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05021952
Other study ID # NIPA AIoT_Cancer
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 21, 2021
Est. completion date May 30, 2024

Study information

Verified date August 2021
Source Seoul St. Mary's Hospital
Contact JIYOUL LEE, Professor
Phone 82-10-8945-3843
Email uroljy@catholic.ac.kr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Recently, the use of mobile health is increasing for the purpose of managing prognosis such as recurrence, survival and quality of life by using a wearable smart band and a smartphone application. In the era of the 4th revolution, mobile health for the purpose of comprehensive prognosis for cancer patients is becoming a very good tool. It is possible to confirm the clinical significance of short-term and temporary health care through a mobile application and a smart band during the treatment process for cancer patients, but the study is insufficient to generalize the number of subjects. Therefore, for prostate cancer patients who need prognosis management after surgery, we will investigate the effect of a mobile application using a smart band which has a modular structure reflecting the treatment method and treatment process after surgery. This study targets patients who underwent prostate cancer surgery. An intervention group (App+IoT device) uses a smart care application for 12 months. This application was tailored for prostate cancer patients and created by reflecting the treatment process after surgery. And they also uses a wearable smart band for 12 months. Control group is provided general education through the hospital brochure. Evaluation will be conducted 2-3days after surgery (before discharge), and at 1, 3, 6, and 12 months after surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 324
Est. completion date May 30, 2024
Est. primary completion date May 30, 2023
Accepts healthy volunteers No
Gender Male
Age group 19 Years to 100 Years
Eligibility Inclusion Criteria: - Patients 19 years of age or older who have been diagnosed with prostate cancer - Patients who have completed surgical treatment for cancer within 3 months of screening and have no additional treatment planned - Patients who can use a prognosis management application and can perform regular follow-up examinations in outpatient settings - Patients carrying an Android or iOS smartphone - Patients who voluntarily decide to participate and give written consent after hearing detailed explanations about this study Exclusion Criteria: - Patients who have been treated within the last 3 months for other serious diseases (hematologic cancer, malignancy, etc.) - Patients for whom additional treatment was planned due to cancer recurrence or metastasis - Patients with severe cardiopulmonary disease who are unable to proceed with rehabilitation exercise programs - Patients who find it difficult to proceed with the rehabilitation exercise program due to pain caused by bone metastasis and concerns about pathological fractures - Patients who underwent lower extremity artificial joint TKRA and THRA - Patients who are not eligible for rehabilitation exercise as judged by medical personnel

Study Design


Related Conditions & MeSH terms


Intervention

Device:
mHealth App and wearable device
An intervention group (App+IoT device) uses a smart care application for 12 months. This application was tailored for prostate cancer patients and created by reflecting the treatment process after surgery. And they also uses a wearable smart band for 12 months.

Locations

Country Name City State
Korea, Republic of Korea University Anam Hospital Seoul Seongbuk-gu

Sponsors (2)

Lead Sponsor Collaborator
Seoul St. Mary's Hospital National IT Industry Promotion Agency

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of body composition (weight, kg) According to time frame with between-group and within group, trends will be found. Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month
Secondary Change of Quality of life (EORTC-QLQ-C30) According to time frame with between-group and within group, trends will be found.
This questionnaire contains 30 items regarding general health status, five functional scales (ie, physical, role, cognitive, emotional, and social functioning), three symptom scales (ie, fatigue, pain, and nausea or vomiting), and six single-item scales (ie, dyspnea, appetite loss, constipation, diarrhea, financial difficulties, and insomnia).
Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month
Secondary Pain (Numeric rating scale, NRS) According to time frame with between-group and within group, trends will be found. NRS score (11 point scales) ranges from 0 (no pain) to 10 (possible to image maximum pain). A higher score means more pain. Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month
Secondary Self-reported symptom and Quality of life (EORTC-QLQ-PR25) According to time frame with between-group and within group, trends will be found. EORTC-QLQ-PR25 consists of 25 questions and identifies various symptoms or problems that patients may experience. Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month
Secondary Physical activity (IPAQ-SF) According to time frame with between-group and within group, trends will be found. IPAQ-SF finds out about the physical activities that patients do on a daily basis. This includes activities that patients do at work or at home, activities they do while using transportation, activities they do in their spare time, and exercise. This questionnaire consists of 7 questions. Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month
Secondary Urination Symptom (ICIQ-SF) According to time frame with between-group and within group, trends will be found. ICIQ-SF is about the urine symptom that patients are experiencing, and consists of a total of 4 questions. Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month
Secondary Overactive Bladder Symptom (OABSS) According to time frame with between-group and within group, trends will be found. OABSS is a questionnaire about overactive bladder symptom and consists of a total of 4 items. Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month
Secondary Prostatic Hyperplasia (IPSS) According to time frame with between-group and within group, trends will be found. IPSS is a questionnaire about prostatic hyperplasia to find out uncomfortable symptoms that may appear when urinating. This questionnaire consists of 8 questions. Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month
Secondary Erectile Dysfunction Symptom (IIEF-5) According to time frame with between-group and within group, trends will be found. IIEF-5 is a questionnaire about the symptoms of erectile dysfunction that may appear after surgery, and consists of 5 questions. Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month
Secondary Grip strength According to time frame with between-group and within group, trends will be found. Using a grip dynamometer, take three measurements on both hands. Higher value (kg) indicates higher grip strength. Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month
Secondary Lower extremity muscle endurance (30seconds chair stands test) According to time frame with between-group and within group, trends will be found. It measures the number of times you sit down and stand up from a chair in 30 seconds. Higher value (number) indicates higher lower extremity muscle endurance.
It is judged that the 30seconds chair stands test will be difficult due to abdominal pain after surgery, so the evaluation is performed only at the other F/U points excluding the enrollment date.
Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month
Secondary 2 Minute walk test (2MWT, evaluation of cardiopulmonary endurance) According to time frame with between-group and within group, trends will be found. The 2MWT is a measurement of endurance that assesses walking distance over two minutes.
It is judged that the 2MWT will be difficult due to abdominal pain after surgery, so the evaluation is performed only at the other F/U points excluding the enrollment date.
Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month
Secondary Nutrition assessment (Mini-nutrition assessment, MNA) According to time frame with between-group and within group, trends will be found. The short form of the MNA (MNASF) is a screening tool consisting of six questions on food intake, weight loss, mobility, psychological stress, or acute disease, the presence of dementia or depression, and body mass index (BMI). The maximum score for this part is equal to 14. A score equal to or higher than 12 indicates that the subject under study has an acceptable nutritional status thus excluding malnutrition and/or malnutrition risk, meanwhile, a score = 11 implicates to proceed with the complete version of the MNA (MNA-LF). This version consists of 12 additional items and provides a maximum possible overall assessment of 30 scores: a score of fewer than 17 indicates malnutrition, a score of 17-23.5 indicates a risk for malnutrition and a score higher 23.5 indicates well-nourishment. Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month
See also
  Status Clinical Trial Phase
Recruiting NCT05540392 - An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues Phase 1/Phase 2
Recruiting NCT05613023 - A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT Phase 3
Recruiting NCT05156424 - A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer Phase 1/Phase 2
Completed NCT03177759 - Living With Prostate Cancer (LPC)
Completed NCT01331083 - A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer Phase 2
Recruiting NCT05540782 - A Study of Cognitive Health in Survivors of Prostate Cancer
Active, not recruiting NCT04742361 - Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer Phase 3
Completed NCT04400656 - PROState Pathway Embedded Comparative Trial
Completed NCT02282644 - Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry N/A
Recruiting NCT06305832 - Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05761093 - Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
Completed NCT04838626 - Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection Phase 2/Phase 3
Recruiting NCT03101176 - Multiparametric Ultrasound Imaging in Prostate Cancer N/A
Completed NCT03290417 - Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer N/A
Active, not recruiting NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed NCT01497925 - Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer Phase 1
Recruiting NCT03679819 - Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
Completed NCT03554317 - COMbination of Bipolar Androgen Therapy and Nivolumab Phase 2
Completed NCT03271502 - Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy N/A